136 related articles for article (PubMed ID: 37976515)
61. Moyamoya disease in China: its clinical features and outcomes.
Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
[TBL] [Abstract][Full Text] [Related]
62. Encephaloduroarteriosynangiosis with Dural Inversion for Moyamoya Disease in a Pediatric and Adult Population-a Single-Center 20-Year Experience.
Goren O; Hendrix P; Peled A; Kimchi G; Zauberman J; Griessenauer C; Feldman Z
World Neurosurg; 2021 May; 149():e16-e21. PubMed ID: 33647488
[TBL] [Abstract][Full Text] [Related]
63. Berlin Grading System Can Stratify the Onset and Predict Perioperative Complications in Adult Moyamoya Disease.
Kashiwazaki D; Akioka N; Kuwayama N; Houkin K; Czabanka M; Vajkoczy P; Kuroda S
Neurosurgery; 2017 Dec; 81(6):986-991. PubMed ID: 28605471
[TBL] [Abstract][Full Text] [Related]
64. Transient Neurological Events After Surgery for Pediatric Moyamoya Disease: A Retrospective Study of Postoperative Sedation Practices.
Matsuura H; Yoshitani K; Nakamori Y; Tsukinaga A; Takahashi JC; Nakai M; Ohnishi Y
J Neurosurg Anesthesiol; 2020 Apr; 32(2):182-185. PubMed ID: 30882554
[TBL] [Abstract][Full Text] [Related]
65. Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
Muraoka S; Araki Y; Kondo G; Kurimoto M; Shiba Y; Uda K; Ota S; Okamoto S; Wakabayashi T
World Neurosurg; 2018 May; 113():e190-e199. PubMed ID: 29432946
[TBL] [Abstract][Full Text] [Related]
66. Time Course of Neoangiogenesis After Indirect Bypass Surgery for Moyamoya Disease : Comparison of Short-term and Long-term Follow-up Angiography.
Zhao Y; Lu J; Zhang Q; Zhang Y; Zhang D; Wang R; Zhao Y
Clin Neuroradiol; 2020 Mar; 30(1):91-99. PubMed ID: 30511151
[TBL] [Abstract][Full Text] [Related]
67. Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population.
Mallory GW; Bower RS; Nwojo ME; Taussky P; Wetjen NM; Varzoni TC; Hanel RA; Meyer FB
Neurosurgery; 2013 Dec; 73(6):984-91; discussion 981-2. PubMed ID: 24030171
[TBL] [Abstract][Full Text] [Related]
68. Risk Factors and Imaging Biomarkers Associated With Perioperative Stroke in Pediatric Moyamoya Arteriopathy.
Gardner Yelton SE; Gatti J; Adil M; Guryildirim M; Tekes A; Sun LR
J Child Neurol; 2022 Dec; 37(12-14):963-969. PubMed ID: 36128779
[TBL] [Abstract][Full Text] [Related]
69. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
[TBL] [Abstract][Full Text] [Related]
70. Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya.
Montaser AS; Lalgudi Srinivasan H; Staffa SJ; Zurakowski D; Slingerland AL; Orbach DB; Hausman-Kedem M; Roth J; Smith ER
J Neurosurg Pediatr; 2022 Apr; 29(4):458-466. PubMed ID: 34972077
[TBL] [Abstract][Full Text] [Related]
71. Adult moyamoya after revascularization.
Gross BA; Du R
Acta Neurochir (Wien); 2013 Feb; 155(2):247-54. PubMed ID: 23108563
[TBL] [Abstract][Full Text] [Related]
72. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
[TBL] [Abstract][Full Text] [Related]
73. The neurosurgical management of Severe Hemophilia A and Moyamoya (SHAM): challenges, strategies, and literature review.
Xu R; Kalluri AL; Sun LR; Lawrence CE; Lee JK; Kannan S; Cohen AR
Childs Nerv Syst; 2022 Jun; 38(6):1077-1084. PubMed ID: 35262754
[TBL] [Abstract][Full Text] [Related]
74. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.
Sakamoto T; Kawaguchi M; Kurehara K; Kitaguchi K; Furuya H; Karasawa J
Anesth Analg; 1997 Nov; 85(5):1060-5. PubMed ID: 9356100
[TBL] [Abstract][Full Text] [Related]
75. Invited article: surgical management of Moyamoya disease.
Ishii K; Fujiki M; Kobayashi H
Turk Neurosurg; 2008 Apr; 18(2):107-13. PubMed ID: 18597224
[TBL] [Abstract][Full Text] [Related]
76. Transient Global Cerebral Hypoperfusion as a Characteristic Cerebral Hemodynamic Pattern in the Acute Stage after Combined Revascularization Surgery for Pediatric Moyamoya Disease: N-Isopropyl-P-[123I] Iodoamphetamine Single-Photon Emission Computed Tomography Study.
Kanoke A; Fujimura M; Tashiro R; Ozaki D; Tominaga T
Cerebrovasc Dis; 2022; 51(4):453-460. PubMed ID: 34933301
[TBL] [Abstract][Full Text] [Related]
77. Chronic Dilatation of Superficial Temporal Artery and Middle Meningeal Artery Associated with Development of Collateral Circulation After Bypass Surgery for Moyamoya Angiopathy.
Ishii D; Okazaki T; Matsushige T; Shinagawa K; Sakamoto S; Oshita J; Kurisu K
World Neurosurg; 2018 Nov; 119():e864-e873. PubMed ID: 30099176
[TBL] [Abstract][Full Text] [Related]
78. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset.
Nakamura A; Takasu S; Seki Y; Saito R
Nagoya J Med Sci; 2024 Feb; 86(1):82-90. PubMed ID: 38505724
[TBL] [Abstract][Full Text] [Related]
79. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
80. Risk Factors for Ischemic Stroke After Revascularization Surgery in Patients with Moyamoya Disease: An Age-Stratified Comparative Meta-Analysis.
Pettersson SD; Olofsson HKL; Ali S; Szarek D; Miękisiak G; Ogilvy CS
World Neurosurg; 2023 May; 173():146-157.e14. PubMed ID: 36716854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
